UPDATED Mar 28, 2024
Get exposure to an age-old industry - tobacco.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LLY | US$15,065.00 | -0.5% | 516.7% | US$701.0b | US$15,442.15 | PE133.7x | E27.2% | 0.7% | ||
LLYD | US$15.70 | 12.1% | 154.4% | US$701.0b | US$16.09 | PE133.7x | E27.2% | 0.7% | ||
DJNJ2 | US$815.00 | 0% | n/a | US$391.1b | US$876.26 | PE28x | E9.4% | 2.9% | ||
DJNJ3 | US$1,190.00 | 0.8% | 140.4% | US$380.6b | US$1,319.52 | PE28.6x | E9.5% | 3.0% | ||
JNJ | US$11,423.50 | 0.04% | 178.0% | US$380.6b | US$12,666.81 | PE28.6x | E9.5% | 3.0% | ||
JNJD | US$11.45 | 1.3% | 7.5% | US$380.6b | US$12.70 | PE28.6x | E9.5% | 3.0% | ||
MRK | US$28,613.50 | 5.0% | 234.8% | US$333.7b | US$29,536.24 | PE915.6x | E25.3% | 2.3% | ||
MRKD | US$26.50 | 0.2% | 20.5% | US$333.7b | US$27.35 | PE915.6x | E25.3% | 2.3% | ||
ABBVD | US$19.20 | 1.6% | 17.8% | US$319.3b | US$19.39 | PE66.9x | E23.1% | 3.4% | ||
ABBV | US$19,519.50 | -0.07% | 207.2% | US$319.3b | US$19,710.74 | PE66.9x | E23.1% | 3.4% | ||
TMO | US$28,416.50 | -3.0% | 177.3% | US$220.9b | US$29,322.98 | PE37x | E10.5% | 0.3% | ||
NVS | CHF26,109.00 | -1.5% | 184.5% | CHF191.3b | CHF29,283.31 | PE24.6x | E9.4% | 3.8% | ||
NVSD | CHF26.50 | -5.7% | n/a | CHF191.3b | CHF29.72 | PE24.6x | E9.4% | 3.8% | ||
AZN | UK£37,027.00 | 1.5% | 166.9% | UK£165.5b | UK£43,238.92 | PE35.3x | E16.4% | 2.1% | ||
AZND | UK£36.85 | 1.0% | 4.4% | UK£165.5b | UK£43.03 | PE35.3x | E16.4% | 2.1% | ||
TMOD | US$27.00 | 0% | n/a | US$200.3b | US$32.62 | PE33.2x | E15.5% | 0.3% | ||
PFE | US$7,541.00 | -1.2% | 86.1% | US$157.3b | US$8,886.65 | PE73.6x | E20.6% | 6.1% | ||
PFED | US$7.47 | 0.1% | -28.9% | US$157.3b | US$8.80 | PE73.6x | E20.6% | 6.1% | ||
AMGND | US$10.50 | 5.0% | n/a | US$153.4b | US$11.26 | PE22.7x | E9.1% | 3.2% | ||
AMGN | US$10,367.50 | 1.9% | 221.1% | US$153.4b | US$11,113.07 | PE22.7x | E9.1% | 3.2% | ||
BMY | US$19,260.50 | 1.7% | 111.1% | US$107.7b | US$20,035.68 | PE13.7x | E7.8% | 4.4% | ||
GILD | US$19,734.00 | -1.7% | 141.1% | US$91.0b | US$23,290.26 | PE16.1x | E6.5% | 4.2% | ||
GILDD | US$19.00 | -1.6% | -9.5% | US$91.0b | US$22.42 | PE16.1x | E6.5% | 4.2% | ||
GSK | UK£11,648.50 | 0.3% | 230.7% | UK£69.8b | UK£13,410.53 | PE14.1x | E9.4% | 3.4% |